IL75280A0 - Lymphokine in pure form,its manufacture,pharmaceutical compositions containing it,monoclonal antibodies thereto,their production and hybridoma cell lines used therefor - Google Patents

Lymphokine in pure form,its manufacture,pharmaceutical compositions containing it,monoclonal antibodies thereto,their production and hybridoma cell lines used therefor

Info

Publication number
IL75280A0
IL75280A0 IL75280A IL7528085A IL75280A0 IL 75280 A0 IL75280 A0 IL 75280A0 IL 75280 A IL75280 A IL 75280A IL 7528085 A IL7528085 A IL 7528085A IL 75280 A0 IL75280 A0 IL 75280A0
Authority
IL
Israel
Prior art keywords
monoclonal antibodies
cell lines
hybridoma cell
human mif
lymphokine
Prior art date
Application number
IL75280A
Other languages
English (en)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of IL75280A0 publication Critical patent/IL75280A0/xx
Priority to IL91476A priority Critical patent/IL91476A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
IL75280A 1984-05-24 1985-05-22 Lymphokine in pure form,its manufacture,pharmaceutical compositions containing it,monoclonal antibodies thereto,their production and hybridoma cell lines used therefor IL75280A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL91476A IL91476A0 (en) 1984-05-24 1989-08-30 Monoclonal antibodies to human macrophage migration inhibition factor(mif),its preparation and its use in the determination of human mif

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH255784 1984-05-24
CH378684 1984-08-07
CH544684 1984-11-14
CH51285 1985-02-05

Publications (1)

Publication Number Publication Date
IL75280A0 true IL75280A0 (en) 1985-09-29

Family

ID=27427909

Family Applications (1)

Application Number Title Priority Date Filing Date
IL75280A IL75280A0 (en) 1984-05-24 1985-05-22 Lymphokine in pure form,its manufacture,pharmaceutical compositions containing it,monoclonal antibodies thereto,their production and hybridoma cell lines used therefor

Country Status (8)

Country Link
EP (1) EP0162812B1 (ja)
JP (3) JPH0672158B2 (ja)
AT (1) ATE93869T1 (ja)
DE (1) DE3587553D1 (ja)
DK (1) DK171646B1 (ja)
ES (3) ES8702950A1 (ja)
IE (1) IE60450B1 (ja)
IL (1) IL75280A0 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8623850D0 (en) * 1986-10-03 1986-11-05 Ciba Geigy Ag Lymphokine related peptide
EP0263072B1 (en) 1986-10-03 1994-03-23 Ciba-Geigy Ag Novel lymphokine related peptides
WO1990011301A1 (en) * 1989-03-17 1990-10-04 Genetics Institute, Inc. Human macrophage migration inhibitory factor
GB8915414D0 (en) * 1989-07-05 1989-08-23 Ciba Geigy Novel cytokines
US5107906A (en) * 1989-10-02 1992-04-28 Swenson Paul F System for fast-filling compressed natural gas powered vehicles
US5149544A (en) * 1989-11-13 1992-09-22 Research Corporation Technologies, Inc. Method of inhibiting progenitor cell proliferation
DE69435303D1 (de) * 1993-05-17 2010-09-02 Cytokine Pharmasciences Inc Er behandlung von krankheiten bei denen eine cytok
US6645493B1 (en) * 1993-05-17 2003-11-11 The Picower Institute For Medical Research Composition containing anti-MIF antibody
US20030235584A1 (en) 2000-02-28 2003-12-25 Kloetzer William S. Method for preparing anti-MIF antibodies
DE10121255A1 (de) 2001-04-30 2002-11-07 Switch Biotech Ag Verwendung von alpha 1-Antichymotrypsin Polypeptiden oder diese kodierende Nukleinsäuren, oder einer ein ACT Polypeptid oder diese kodierende Nukleinsäure exprimierende Zelle, zur Behandlung und/oder Prävention von diabetes-assoziierten und/oder arteriellen schlecht heilenden Wunden und zur Identifizierung von pharmakologisch aktiven Substanzen
MY140679A (en) 2001-05-24 2010-01-15 Avanir Pharmaceuticals Inhibitors of macrohage migration inhibitory factor and methods for identifying the same
TW200418829A (en) 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
CA2600175A1 (en) 2005-03-24 2006-03-20 Avanir Pharmaceuticals Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
CN100457895C (zh) * 2006-05-24 2009-02-04 中国科学院生物物理研究所 鼠抗人巨噬细胞迁移抑制因子单克隆抗体及其应用
WO2013050453A1 (en) 2011-10-07 2013-04-11 Baxter Healthcare S.A. Oxmif as a diagnostic marker

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2755363C3 (de) * 1977-12-12 1983-12-01 R & Z Biologicals Beteiligungsgesellschaft mbH, 4050 Mönchengladbach Testverfahren zur Diagnose von Malignomen
US4299814A (en) * 1979-05-25 1981-11-10 Monsanto Company Radioimmunoassay of MIF
JPS5939832A (ja) * 1982-08-28 1984-03-05 Ajinomoto Co Inc モノクロ−ナル抗体ならびにその製法、使用法
DD230876A1 (de) * 1983-05-09 1985-12-11 Akad Wissenschaften Ddr Verfahren zur gewinnung monoklonaler antikoerper gegen human-mif

Also Published As

Publication number Publication date
JPH07108915B2 (ja) 1995-11-22
JPS60248617A (ja) 1985-12-09
JPH06217789A (ja) 1994-08-09
DK229985A (da) 1985-11-25
ES8801852A1 (es) 1988-02-16
IE60450B1 (en) 1994-07-13
DK229985D0 (da) 1985-05-23
JPH0672158B2 (ja) 1994-09-14
ES543391A0 (es) 1987-01-16
ATE93869T1 (de) 1993-09-15
DK171646B1 (da) 1997-03-03
DE3587553D1 (de) 1993-10-07
EP0162812A2 (de) 1985-11-27
EP0162812B1 (de) 1993-09-01
EP0162812A3 (en) 1988-04-20
JPH0780915B2 (ja) 1995-08-30
IE851295L (en) 1985-11-24
ES8702950A1 (es) 1987-01-16
ES557072A0 (es) 1987-08-01
ES8801850A1 (es) 1987-08-01
JPH0770192A (ja) 1995-03-14
ES557071A0 (es) 1988-02-16

Similar Documents

Publication Publication Date Title
IL75280A0 (en) Lymphokine in pure form,its manufacture,pharmaceutical compositions containing it,monoclonal antibodies thereto,their production and hybridoma cell lines used therefor
Van Damme et al. Separation and comparison of two monokines with lymphocyte-activating factor activity: IL-1 beta and hybridoma growth factor (HGF). Identification of leukocyte-derived HGF as IL-6.
Van Damme et al. Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor.
NO165556C (no) Monoklonale antistoff samt derivater derav med hoey affinitet til human-renin og sturkturelt lignende renin for in vitro anvendelse.
Koyasu et al. Production of interleukin 3 and gamma-interferon by an antigen-specific mouse suppressor T cell clone.
DK113389A (da) Monoklonale antistoffer
ATE245699T1 (de) Rekombinant pgp3, verfahren zu dessen herstellung,und dessen verwendung in der diagnose und therapie
Chen et al. Production of osteoclast‐activating factor by normal human peripheral blood rosetting and nonrosetting lymphocytes
DK118682A (da) Anigiotropiner fra leucocyter og inflammationsvaev samt fremgangsmaade til fremstilling deraf
DE3855747D1 (de) Biologische materialien, deren herstellung und verwendung in der therapie
AU608216B2 (en) Interferon-induced human protein in pure form, monoclonal antibodies thereto, and test kits containing these antibodies
Hardwicke et al. Human α1-glycoproteins Separation from pathological urine and examination by immunological and electrophoretic methods
Köck et al. Characterization of a monoclonal antibody directed against the biologically active site of human interleukin 1.
Kishimoto et al. Polymorphism of submandibular-sublingual salivary proteins which promote adhesion of Streptococcus mutans serotype-c strains to hydroxyapatite
Knudsen et al. Elevated intracellular cAMP levels inhibit interleukin-1 production by the tumour cell line U937
Nishihara et al. Production of an interleukin-1 inhibitor by cell line P388D1 murine macrophages stimulated with Haemophilus actinomycetemcomitans lipopolysaccharide
Larsson et al. Characterization of a human mitogenic factor (MF) released by phytohemagglutinin-activated lymphocytes
Van Damme et al. IDENTIFICATION OF THE HUMAN 26-kD PROTEIN, INTERFERON 02 (IFN-N2), AS AB CELL HYBRIDOMA/PLASMACYTOMA GROWTH FACTOR INDUCED BY INTERLEUKIN 1 AND TUMOR NECROSIS FACTOR
ATE229983T1 (de) Maspin- ein neues serpin mit tumor unterdrückender aktivität
DE19529026C2 (de) Monoklonale Antikörper gegen humanes Interleukin-10
Kull Jr et al. Macrophage cytotoxin: Sources and mechanism
FR2587035B1 (fr) Procede de production d'ethanol par fermentation de milieux sucres
JPH02282399A (ja) リンホカイン　ｓａｆ
HUT34547A (en) Process for the purification of proteins isolated from microbe cultures
Lachman Monoclonal antibody to human IL 1 and hybrid cell lines secreting IL 1